•If month and day are missing, then the month and day will be set to July 1st. C urative intent treatment dates for select treatments are cap tured for all subjects. The number of subjects receiving these treatments will be summarized using frequency counts and percentages. “Other” curative intent treatment will be collected and the number of subjects receiving these treatments will be summarized by treatment class and generic trade name, or by treatment class and drug name if generic trade name is missing, using frequency counts and percentages. P SA values for the 6 months prior to dosing for each subject will be presented in the data listing s.